All true but what many have forgotton is that it is the only non resistant AB to bacteria drug under development.due to it killing the bacteria rather than slowing its reproduction down like others
100k deaths in the US last year from resistent AB infections. I'm sure this has not alluded any partners wishing to take up the baton with MTFB - its success has global implications.
Don’t think those figures are right either. Pru sold 5.5pc and Invesco ditched around 12pc on Feb 14th. So Ii figure no way near.
Then Amp sales
Plus , tbh, existing iis have little choice